Global Trade Alert
Global Trade Alert

France: EIB and OSE Immunotherapeutics sign EUR 25 million loan for RDI strategy

Announcement

12 Feb 2021

In February 2021, the European Investment Bank (EIB) and OSE Immunotherapeutics signed a EUR 25 million (approx. USD 30.3 million) loan to support the company’s RDI activities.

Source

Sign in to access

Number of interventions

2

2 certainly harmful

0 likely harmful

0 liberalising

List of interventions

2 in force

Implementation date

12 Feb 2021

Revocation date:

No revocation date

State loan In force

On 12 February 2021, the European Investment Bank (EIB) and OSE Immunotherapeutics signed a EUR 25 million (approx. USD 30.3 million) loan to support the company’s RDI investment in the development of...

Sign in to see more
Loan guarantee In force

The EIB's loan for the amount of EUR 25 million (approx. USD 30.3 million) loan with OSE Immunotherapeutics, signed on 12 February 2021, formed part of the EIB’s strategy to support biotech companies ...

Sign in to see more

Threads

See all

This state act is not part of any Thread yet.